Prevalence
Clinical
features
Differential
diagnosis
Investigations
Therapy
Prevention
Prognosis
|  |  | | Therapy |
Angioplasty
Offer angioplasty a
to patients with single vessel disease.
b
Why?
-
Patients with non-acute coronary artery disease who have angioplasty compared with medical therapy have less angina
a
and require less medication. a
-
There is no clear effect on death or myocardial infarction.
a
-
Patients who have angioplasty are more likely to require a CABG, but
not clearly more likely to require further angioplasty. a
Angioplasty reduces angina but increases the
risk of CABG compared with medical therapy
Patient a
 |
Treatment |
Comparison |
Outcome |
CER |
OR (95% CI) |
NNT
(95% CI) |
|
non-acute coronary artery disease
|
angioplasty
|
medical therapy
|
angina
at 3 years
|
71%
|
0.70
(0.50 to 0.98)
|
13
(6 to 240)
|
|
|
angioplasty
|
medical therapy
|
CABG
at 3 years
|
4.1%
|
1.59
(1.09 to 2.32)
|
-44
(-280 to -20)
|
Angioplasty reduces need for antianginal
medication compared with medical therapy
Patient a
|
Treatment |
Comparison |
Outcome |
CER |
RRR (95% CI) |
NNT
(95% CI) |
|
coronary artery disease with >50% stenosis in at least 1 vessel
|
angioplasty +/- stent
|
medical therapy
|
on 1 or fewer anti-anginal drugs
at 3 years
|
47%
|
-60%
(-90% to
-35%)
|
4
(3 to
5)
|
|